Health care leaders may want to keep a closer eye on clinical validation for artificial intelligence (AI)-enabled medical devices (AIMDs), based on a recent JAMA Health Forum study.
FDA clearance is a vital milestone for ASX medical device companies, opening access to the US market while navigating the ...
Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...
The CDx System is a combination medical device consisting of the OncoGuide™ OncoScreen™ Plus CDx Kit and the OncoGuide™ ...
Rapid release testing detects mycoplasma DNA with great sensitivity by using advanced technologies such nucleic acid ...
LLC, a pioneer in sterilization assurance technology, is reinforcing its commitment to advancing sterilization science with a ...
A new study applying multi-omics techniques and machine learning identified 33 plasma proteins that differ significantly in ...
Astronauts with diabetes may soon be able to undertake space missions safely, a study conducted during Shubhanshu Shukla's ...
The Smart Sleep Tracker Market is experiencing rapid growth, driven by rising health awareness, increasing adoption of wearable devices, and integration ...